Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

UTHR Quotes by TradingView

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $52,404. The most recent transaction as insider was on Apr 10, 2024, when has been sold 13,800 shares (Common Stock) at a price of $235.83 per share, resulting in proceeds of $3,254,454. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130
0% 3M change
0% 12M change
Total Value Held $52,404

MARTINE A ROTHBLATT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 10 2024
SELL
Open market or private sale
$3,254,454 $235.83 p/Share
13,800 Reduced 99.07%
130 Common Stock
Apr 10 2024
BUY
Exercise of conversion of derivative security
$1,786,962 $129.49 p/Share
13,800 Added 49.77%
13,930 Common Stock
Apr 09 2024
SELL
Open market or private sale
$3,556,950 $237.13 p/Share
15,000 Reduced 99.14%
130 Common Stock
Apr 09 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Apr 08 2024
SELL
Open market or private sale
$1,198,157 $236.79 p/Share
5,060 Reduced 97.5%
130 Common Stock
Apr 08 2024
BUY
Exercise of conversion of derivative security
$655,219 $129.49 p/Share
5,060 Added 49.37%
5,190 Common Stock
Apr 05 2024
SELL
Open market or private sale
$3,513,450 $234.23 p/Share
15,000 Reduced 99.14%
130 Common Stock
Apr 05 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Apr 04 2024
SELL
Open market or private sale
$3,490,350 $232.69 p/Share
15,000 Reduced 99.14%
130 Common Stock
Apr 04 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Apr 03 2024
SELL
Open market or private sale
$3,436,650 $229.11 p/Share
15,000 Reduced 99.14%
130 Common Stock
Apr 03 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Apr 02 2024
SELL
Open market or private sale
$3,435,000 $229.0 p/Share
15,000 Reduced 99.14%
130 Common Stock
Apr 02 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Apr 01 2024
SELL
Open market or private sale
$3,399,300 $226.62 p/Share
15,000 Reduced 99.14%
130 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 28 2024
SELL
Open market or private sale
$3,350,308 $237.19 p/Share
14,125 Reduced 99.09%
130 Common Stock
Mar 28 2024
BUY
Exercise of conversion of derivative security
$1,829,046 $129.49 p/Share
14,125 Added 49.77%
14,255 Common Stock
Mar 27 2024
SELL
Open market or private sale
$3,634,350 $242.29 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 27 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 26 2024
SELL
Open market or private sale
$3,718,200 $247.88 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 26 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 25 2024
SELL
Open market or private sale
$3,662,100 $244.14 p/Share
15,000 Reduced 99.14%
130 Common Stock
Mar 25 2024
BUY
Exercise of conversion of derivative security
$1,942,350 $129.49 p/Share
15,000 Added 49.78%
15,130 Common Stock
Mar 22 2024
SELL
Open market or private sale
$3,547,350 $236.49 p/Share
15,000 Reduced 99.14%
130 Common Stock
MAR

Martine A Rothblatt

Chairperson & CEO
Silver Spring, MD

Track Institutional and Insider Activities on UTHR

Follow UNITED THERAPEUTICS Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

News

Receive news related to UNITED THERAPEUTICS Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on UTHR